GlassScriptPhysician profile
Steven P Davison
NPI 1003814062
$6,795.57
in general payments reported to CMS, 2019-2025
16 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,282 · 2020: $173 · 2021: $684 · 2022: $913 · 2023: $564 · 2024: $547 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,743.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,596.72 | 2019-2022 | |
| Mentor Worldwide LLC | $984.03 | 2019-2025 | Mentor Cpx 2 Breast Tissue Expander, Mentor Siltex Round Spectrum, Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $547.94 | 2022-2025 | Integra, Tenoglide, Primatrix |
| Abbvie INC. | $361.79 | 2023-2025 | Botox |
| Bard Peripheral Vascular, INC. | $277.17 | 2021 | |
| Axogen | $197.51 | 2022-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Cap |
| Galderma Laboratories, L.P. | $186.21 | 2019-2025 | |
| Tela Bio, INC. | $180.88 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $139.15 | 2021 | |
| Motiva USA, LLC | $107.15 | 2025 | |
| Innovation Technologies INC | $87.81 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $43.19 | 2024-2025 | Exparel |
| Davol INC. | $28.67 | 2025 | Arista |
| Vertex Pharmaceuticals Incorporated | $24.81 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.25 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Davison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.